Delivery Order SPE2DB20D3303-SPE2DB25FA2QQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,780.40 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation medication in 4-gram quantities. This non-set-aside, firm fixed price delivery order was competitively awarded and has an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,844.50 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation solution (4 gm). This competitively awarded, firm fixed-price contract has a completion date of June 11, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $5,790.98 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a $3,470.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Spiriva Respimat 1.25 mcg inhalation medication in 4-gram quantities. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside designation. Performance will be completed at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.40 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $13,429.73 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 grams) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,562.12 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4gm) with an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting open competition in federal procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,042.65 delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhalation medication (4 gm) with an ultimate completion date of August 1, 2025. This competitive award, utilizing firm fixed pricing, was issued with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4-gram quantities, with a ceiling value of $1,277.09. This firm fixed-price delivery order, which must be completed by August 15, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2QQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,848.20 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 grams) with a completion date of August 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies an extensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements across diverse therapeutic domains through competitively awarded delivery orders with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/15/25 |